AronenHJGazitIE: Cerebral blood volume maps of gliomas: Comparison with tumor grade and histologicic findings. Radiology191: 41–51, 1994.
2.
BirkenDLOldendorfWH: N-acetyl-aspartic acid: A literature review of a compound prominent in 1H-NMR spectroscopic studies of the brain. Neurosci Biobehav Rev13: 23–31, 1989.
3.
BottomleyPA: Human in vivo NMR spectroscopy in diagnostic medicine: Clinical tool or research probe?Radiology170: 1–15, 1989.
4.
BruhnHFrahmJ: Non invasive differentiation of tumors with use of localized H-1 MR spectroscopy in vivo: Initial experience in patients with cerebral tumors. Radiology172: 541–548, 1989.
5.
ByrdSETomitaT: Magnetic resonance spectroscopy in the evaluation of pediatric brain tumors, Part II: Clinical analysis. J Natl Med Assoc88: 717–723, 1996.
6.
CastilloMKwochLMukherjiSK: Clinical applications of proton MR spectroscopy. Am J Neuroradiol17: 1–15, 1996.
7.
CastilloMKwockL: Proton MR spectroscopy of common brain tumors. Neuroimag Clin North Am4: 733–752, 1998.
8.
CastilloMSmithJKKwockL: Correlation of Myo-inositol levels and grading of cerebral astrocytomas. Am J Neuroradiol21: 1645–1649, 2000.
9.
DanielsenERRossB: Magnetic resonance spectroscopy diagnosis of neurological diseases. New York, Marcel Decker: 30–34, 1999.
10.
DavieCAHawkinsCP: Detection of myelin breakdown products by proton magnetic resonance spectroscopy. Lancet341 (8845): 630–631, 1993.
11.
FrahmJBruhnH: Localized proton NMR spectroscopy of brain tumors using short echo time STEAM sequences. J Comput Assist Tomogr15 (6): 915–922, 1991.
12.
FulhamMJBizziA: Mapping of brain tumour metabolites with proton MR spectroscopic imaging: Clinical relevance. Radiology185: 675–686, 1992.
13.
KinoshitaKTadaE: Proton MR spectroscopy of delayed cerebral radiation in monkeys and humans after brachyterapyAm J Neuroradiol18: 1753–1761, 1997.
14.
KugelHHeindelW: Human brain tumours: Spectral patterns detected with localized H-1 MR spectroscopyRadiology183: 701–709, 1992.
15.
OttDHennigJErnstT: Human brain tumours: Assessment with in vivo proton MR spectroscopy. Radiology186: 745–752, 1993.
16.
PoptaniHGuptaRK: Characterization of intracranial mass lesions with in vivo proton ME spectroscopy. Am J Neuroradiol16: 1593–1603, 1995.
17.
RandSDProstR: Accuracy of single-voxel proton MR spectroscopy in distinguishing neoplastic from non neoplastic brain lesions. Am J Neuroradiol18: 1695–1704, 1997.
18.
RemyCFouilheN: Evidence that mobile lipids detected in rat brain glioma by 1H Nuclear magnetic resonance corresponds to lipid droplets. Cancer Res57: 407–414, 1997.
19.
RossBDMichaelisT: Clinical applications of magnetic resonance spectroscopy. Mag Reson Q4: 191–247, 1994.
20.
SchlemmerHPBachertP: Differentiation of radiation necrosis from tumour progression using proton magnetic resonance spectroscopyNeuroradiology44: 216–222, 2002.
21.
UseniusJPKauppinenRA: Quantitative metabolite patterns of human brain tumours: Detection by 1H NMR spectroscopy in vivo and in vitro. J Comput Assist Tomogr18: 705–713, 1994.
22.
UseniusTUseniusJP: Radiation-induced changes in human brain metabolites as studied by 1H nuclear magnetic resonance spectroscopy in vivo. Int J Rad Oncol Biol Phys33: 719–724, 1995.